| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 18 |
| 1 | METHOTREXATE | 17 |
| 2 | ASPIRIN | 16 |
| 3 | ASPIRIN 325 MG | 16 |
| 4 | ASPIRIN 81 MG | 16 |
| 5 | ETANERCEPT | 16 |
| 6 | CANAGLIFLOZIN | 13 |
| 7 | INFLIXIMAB | 13 |
| 8 | ADALIMUMAB | 11 |
| 9 | INTERFERON BETA-1A | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE OINTMENT | 1 | 0.0500 |
| 1 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 2 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 3 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 4 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 5 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 6 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 7 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 8 | CEFADROXIL | 2 | 0.0010 |
| 9 | NISOLDIPINE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 30 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Corticosteroid [EPC] | 19 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 5 | Insulin Analog [EPC] | 10 |
| 6 | Interferon beta [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Benzodiazepine [EPC] | 9 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 5 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 6 | Oxazolidinone Antibacterial [EPC] | 5 | 0.0002 |
| 7 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |